{"id":"W2060821918","doi":"10.1016/j.yebeh.2014.09.061","title":"Efficacy of once-daily extended-release topiramate (USL255): A subgroup analysis based on the level of treatment resistance","year":2014,"lang":"en","type":"article","venue":"Epilepsy & Behavior","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"UCB Pharma; H. Lundbeck A/S; Upsher-Smith; SK Life Science; Valeant Pharmaceuticals International; Eisai; Sunovion","keywords":"Topiramate; Medicine; Placebo; Drug Resistant Epilepsy; Clinical endpoint; Clinical Global Impression; Epilepsy; Subgroup analysis; Internal medicine; Post-hoc analysis; Drug; Adjunctive treatment; Clinical trial; Anesthesia; Pharmacology; Psychiatry; Meta-analysis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002903307,0.0006296061,0.002288922,0.0005716583,0.0001529144,0.0005725019,0.0003312913,0.0004304243,0.001202284],"category_scores_gemma":[0.001590721,0.0001645258,0.003538249,0.0003576626,0.0002519913,0.0003399751,0.0002960181,0.0005238568,0.0001164822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003243904,"about_ca_system_score_gemma":0.0003759746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004504074,"about_ca_topic_score_gemma":0.001356205,"domain_scores_codex":[0.9989171,0.0004360415,0.0001967375,0.0001850607,0.0001486998,0.0001163068],"domain_scores_gemma":[0.9991319,0.0003715205,0.0001994232,0.0001482375,0.0000560314,0.00009308589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7160978,0.001518108,0.1270652,0.001489701,0.03605516,0.0007177943,0.0002870886,0.00199943,0.03609599,0.0002339237,0.001184773,0.07725509],"study_design_scores_gemma":[0.07275842,0.1297357,0.7345294,0.0001284754,0.03869683,0.001238311,0.0004048389,0.005342989,0.01254733,0.0006046235,0.00385986,0.0001532696],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965454,0.001657222,0.0003837848,0.00004998606,0.00002810686,0.0002445683,0.0006262016,0.00001956831,0.0004450936],"genre_scores_gemma":[0.9979475,0.0002901868,0.0003314436,0.00007984431,0.00003601904,0.000155531,0.0008855644,0.000007388776,0.000266488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002903307,"threshold_uncertainty_score":0.01535439,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06200573374235775,"score_gpt":0.3327966102095909,"score_spread":0.2707908764672332,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}